KENNETH WRIGHT: Open Payments
NPI 1043328834 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 30 payments from 12 companies in 2025. Trend: 2023 $161 · 2024 $103 · 2025 $656
Food & beverage: $557Education: $99
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $218 |
| Janssen Biotech, Inc. | 1 | $99 |
| UCB, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $69 |
| Medtronic, Inc. | 3 | $54 |
| Organon LLC | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Biofrontera Inc. | 1 | $17 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, TALTZ, DUPIXENT, SYNCHROMEDII, ANZUPGO, Rhapsido.
Industry payments across TX — which companies pay providers there.
